Inducing ferroptosis, facilitated by m6A modification of ATG5 mRNA mediated by WTAP and YTHDC2, effectively suppresses hepatocellular carcinoma development, highlighting a promising therapeutic approach. This evidence concerns the gene YTHDC2 and hepatocellular carcinoma.